A review of whole animal bioassays of the carcinogenic potential of naphthalene

Regulatory Toxicology and Pharmacology

Volumn 51, Issue 2 SUPLL, 2008, Pages 6-14

  North, D Warner ^a,b   Abdo, Kamal M ^c   Benson, Janet M ^d   Dahl, Alan R ^e   Morris, John B ^f   Renne, Roger ^g   Witschi, Hanspeter ^h  

^a NorthWorks Inc   (United States)

^b Stanford University   (United States)

^c NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^d LOVELACE RESPIRATORY RESEARCH INSTITUTE   (United States)

^e OHIO STATE UNIVERSITY   (United States)

^f UNIVERSITY OF CONNECTICUT   (United States)

^g PACIFIC NORTHWEST NATIONAL LABORATORY   (United States)

^h UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Animal bioassay; Cancer; Carcinogenesis; Cytotoxicity; Inhalation studies; Maximum tolerated dose (MTD); Naphthalene; National Toxicology Program (NTP); Tumorigenesis

Indexed keywords

NAPHTHALENE;

ARTICLE; BIOASSAY; CANCER RISK; CONTROLLED STUDY; CYTOTOXICITY; EXPOSURE; FEMALE; LUNG ADENOMA; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SEX DIFFERENTIATION;

ANIMALIA; MUS; RATTUS;

EID: 44649090156     PISSN: 02732300     EISSN: 10960295     Source Type: Journal    
DOI: 10.1016/j.yrtph.2007.09.022     Document Type: Article

References (33)

1. Abdo K.M., Eustis S.L., McDonald M., Jokinen M.P., Adkins Jr. B., and Haseman J.K. Naphthalene: a respiratory tract toxicant and carcinogen for mice. Inhal. Toxicol. 4 4 (1992) 393-509
2. Abdo K.M., Grumbein S., Chou B.J., and Herbert R. Toxicity and carcinogenicity in F344 rats following 2 years of whole-body exposure to naphthalene vapors. Inhal. Toxicol. 13 10 (2001) 931-950
3. Adkins Jr. B., Van Stee E., Simmons J., and Eustis S. Oncogenic response of strain A/J mice to inhaled chemicals. J. Toxicol. Environ. Health, A. 17 (1986) 311-322
4. American Conference of Governmental Industrial Hygienists (ACGIH), 1990. Threshold Limit Values for Chemical Substances and Physical Agents and Biological Exposure Indices. Cincinnati, OH.
5. Baldwin R.M., Jewell W.T., Fanucchi M.V., Plopper C.G., and Buckpitt A.R. Comparison of pulmonary/nasal CYP2F expression levels in rodents and Rhesus Macaque. J. Pharmacol. Exp. Ther. 309 (2004) 127-136
6. Belzer R.B., Bus J.S., Cavalieri E.L., Lewis S.C., North D.W., and Pleus R.C. Naphthalene State of the Science Symposium: objectives, organization, structure, and charge. Regul. Toxicol. Pharmcol. 51 Suppl. 1 (2008) S1-S5
7. Bogen K.T., Benson J.M., Clewell H.J., Dahl A.R., Krishnan K., Morris J.B., Omiecinski C.J., and Yost G.S. Naphthalene metabolism in relation to target tissue anatomy, physiology, cytotoxicity and tumorigenic mechanism of action. Regul. Toxicol. Pharmcol. 51 Suppl. 1 (2008) S27-S36
8. Brown H.R. Neoplastic and potentially preneoplastic changes in the upper respiratory tract of rats and mice. Environ. Health Perspect. 85 (1990) 291-304
9. Brown H.R., Monticello T.M., Maronpot R.R., Randall H.W., Hotchkiss J.R., and Morgan K.T. Proliferative and neplastic lesions in the rodent nasal cavity. Toxicol. Pathol. 19 (1991) 358-372
10. Brusick D.J., Small M.S., Cavalieri E.L., Chakravarti D., Ding X., Longfellow D.G., Nakamura J., Rogan E.G., and Swenberg J.A. Possible genotoxic modes of action for naphthalene. Regul. Toxicol. Pharmcol. 51 Suppl. 1 (2008) S43-S50
11. Buckley L.A., Morgan K.T., Swenberg J.A., Hamm Jr. T.E., and Barrow C.S. The toxicity of dimethylamine in F-344 rats and B6C3F1 mice following a 1-year inhalation exposure, Fundam. Appl. Toxicol. 5 2 (1985) 341-352
12. Dahl A.R., and Henderson R.F. Comparative metabolism of butadiene and its monoepoxide in human and monkey hepatic microsomes. Inhal. Toxicol. 12 (2000) 439-451
13. Graziadei P.P., and Graziadei G.A. Neurogenesis and neuron regeneration in the olfactory system of mammals. I. Morphological aspects of differentiation and structural organization of the olfactory sensory neurons. J. Neurocytol. 8 1 (1979) 1-18
14. Griego F.Y., Bogen K.T., Price P.S., and Weed D.L. Exposure, epidemiology and human cancer incidence of naphthalene. Regul. Toxicol. Pharmcol. 51 Suppl. 1 (2008) S22-S26
15. Haseman J.K., and Hailey J.R. An update of the National Toxicology Program database on nasal carcinogens. Mutat. Res. 380 1-2 (1997) 3-11
16. Henderson R.F., Bechtold W.E., Sabourin P.J., Maples K.R., and Dahl A.R. Species differences in in vivo metabolism of 1,3-butadiene. Toxicology 113 (1996) 17-22
17. Henderson R.F., Bechtold W.E., Thorton-Manning J.R., and Dahl A.R. Urinary butadiene diepoxide: a potential biomarker of blood diepoxide. Toxicology 160 1-3 (2001) 81-86
18. Henderson R.F., Hahn F.F., Benson J.M., Barr E.B., Bechtold W.E., Burt D.G., and Dahl A.R. Dosimetry and acute toxicity of inhaled butadiene diepoxide in rats and mice. Toxicol. Sci. 51 1 (1999) 148-152
19. Knake E. Uber Schwache gesewlsterzeugende Wirkung von Naphthalene und Benzol. Virchows Arch. Pathol. Anat. Physiol. 329 (1956) 141-176
20. Long P.H., Herbert R.A., Peckham J.C., Grumbein S.L., Shackleford C.C., and Abdo K. Morphology of nasal lesions in F344/N rats following chronic inhalation exposure to naphthalene vapors. Toxicol. Pathol. 31 (2003) 655-664
21. Moulton D.G. Dynamics of cell proliferation in the olfactory epithelium. Ann. N. Y. Acad. Sci. 237 (1974) 52-61
22. National Research Council (NRC), 1993. Use of the maximum tolerated dose in animal bioassays for carcinogenicity. In: Issues in Risk Assessment, National Academy Press, Washington, DC, pp. 15-183.
23. National Research Council (NRC), 1994. Science and Judgment in Risk Assessment. National Academy Press, Washington, DC.
24. National Toxicology Program (NTP), 1992. Toxicology and Carcinogenesis Study of Naphthalene in B6C3F1 Mice (Inhalation Studies). Technical Report Series No. 410. National Toxicology Program, Research Triangle Park, NC.
25. National Toxicology Program (NTP), 2000. Toxicology and Carcinogenesis Study of Naphthalene in F344/N Rats (Inhalation Studies). Technical Report Series No. 500. National Toxicology Program, Research Triangle Park, NC.
26. Price P.S., and Jayjock M.A. Available data on naphthalene exposures: strengths and limitations. Regul. Toxicol. Pharmcol. 51 Suppl. 1 (2008) S15-S21
27. Pino M.V., Valerio M.G., Miller G.K., Larson J.L., Rsolia D.L., Jayyosi Z., Crouch C.N., Trorjanowski J.Q., and Geiger L.E. Toxicologic and carcinogenic effects of the Type IV phosphodiesterase inhibitor RP 73401 on the nasal olfactory tissues in rats. Toxicol. Pathol. 27 (1999) 383-394
28. Schmahl D. Prüfung von Naphthalin und Anthracen auf cancerogene Wirkung an Ratten. Zeit. Krebsforsch. 60 (1955) 697-710
29. Thornton-Manning J.R., Dahl A.R., Allen M.L., Bechtold W.E., Griffith Jr. W.C., and Henderson R.F. Disposition of butadiene epoxides in Sprague-Dawley rats following exposures to 8000 ppm 1,3-butadiene: comparisons with tissue epoxide concentrations following low-level exposures. Toxicol. Sci. 41 (1998) 167-173
30. Thornton-Manning J.R., Dahl A.R., Bechtold W.E., Griffith Jr. W.C., and Henderson R.F. Comparison of the disposition of butadiene epoxides in Sprague-Dawley rats and B6C3F1 mice following single and repeated exposures to 1,3-butadiene via inhalation. Toxicology 123 (1997) 125-134
31. Thornton-Manning J.R., Hotchkiss J.A., Rohrbacher K.D., Ding X., and Dahl A.R. Nasal cytochrome P450 2A: identification, regional localization, and metabolic activity toward hexamethylphosphoramide, a known nasal carcinogen. Toxicol. Appl. Pharmacol. 142 1 (1997) 22-30
32. Thornton-Manning J.R., Dahl A.R., Bechtold W.E., and Henderson R.F. Gender and species differences in the metabolism of 1,3-butadiene to butadiene monoepoxide and butadiene diepoxide in rodents following low-level inhalation exposures. Toxicology 113 (1996) 322-325
33. West J.A.A., Pakehham G., Morin D., Fleschner C.A., Buckpitt A.R., and Plopper C.G. Inhaled naphthalene causes dose dependent Clara cell cytotoxicity in mice but not in rats. Toxicol. Appl. Pharmacol. 173 2 (2001) 114-119